---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-23-003826"
form_type: "8-K"
ticker: "XBIO"
cik: "0001534525"
company_name: "Xenetic Biosciences, Inc."
filed_at: "2023-06-02T23:59:59+00:00"
generated_at: "2026-06-14T08:10:54.673172+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Xenetic Biosciences regains Nasdaq minimum bid price compliance

## Summary
- Received Nasdaq letter on May 30, 2023 confirming compliance with Listing Rule 5550(a)(2).
- Compliance achieved after closing bid price >= $1.00 for 10 consecutive days (May 15-26, 2023).
- Previous deficiency was notified on June 3, 2022; this matter is now closed.

## SEC filing metadata
- accession: 0001683168-23-003826
- form_type: 8-K
- ticker: XBIO
- cik: 0001534525
- company_name: Xenetic Biosciences, Inc.
- filed_at: 2023-06-02T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534525/000168316823003826/0001683168-23-003826-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534525/000168316823003826/xenetic_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-23-003826
- JSON: https://secwatch.observer/filing/0001683168-23-003826.json
- Plain text: https://secwatch.observer/filing/0001683168-23-003826.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.